학술논문
Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients
Document Type
Article
Author
Source
In: International Journal of Hematology . (International Journal of Hematology, June 2021, 113(6):777-784)
Subject
Language
English
ISSN
18653774
09255710
09255710